8-K current report · filed Jul 23, 2026

Gentherm Inc (THRM) 8-K Current Report: July 23, 2026

Item 2.02Item 7.01Item 8.01Item EX-99.1THRM overview

Short answer

Gentherm Inc (THRM) filed an 8-K current report with the SEC on July 23, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results publicly released on July 23, 2026.

Gentherm Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q2 2026 financial results publicly released on July 23, 2026
  • Full-year 2026 guidance updated, signaling revised management expectations
  • Detailed results and guidance available in Exhibit 99.1

Item 7.01 · Regulation FD Disclosure

  • Q2 2026 results conference call scheduled for July 23, 2026 at 8:00 a.m. Eastern Time
  • Management will update investors on full-year 2026 guidance
  • Supplemental presentation available through Gentherm’s Investor Events webpage
  • Disclosure furnished under Regulation FD, not filed under Exchange Act Section 18

Item 8.01 · Other Events

  • 2024 buyback terminated July 27, 2026, with $110.1 million of authorization remaining
  • New $400 million repurchase authorization through July 27, 2029, materially expanding capital-return capacity
  • Repurchases discretionary and subject to cash needs, market conditions, debt covenants, and other capital uses
  • Funding may include cash, borrowings, or future equity and debt offerings, creating potential leverage or dilution considerations

Item EX-99.1 · Exhibit EX-99.1

  • Q2 product revenue reached record $416.2M, up 11.0% year over year and 9.5% excluding foreign exchange
  • Automotive Climate and Comfort Solutions grew 14.1%, outperforming relevant-market vehicle production by 14 percentage points
  • Adjusted EPS rose to $0.75 from $0.54, while adjusted EBITDA increased to $48.8M; margin declined to 11.7% from 12.2%
  • 2026 guidance increased to $1.55B–$1.65B revenue and $185M–$200M adjusted EBITDA
  • New $400M repurchase authorization replaces the prior program on July 27, alongside medical acquisition and Modine transaction targeted for early Q4 2026

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Gentherm Inc 8-K filings

Get the next THRM 8-K as it lands

Follow THRM for push alerts, or ask the research agent what this filing means.